NCT03914794 2025-10-03A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk TumorsSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2 Completed30 enrolled